# Patrick Aisher > Patrick Aisher is a seed investor at MedScience Ventures backing Health Care and Medical Device. See 5 investments, check sizes, portfolio. Updated Aug 2026. - Type: Angel Investor - Fund: [MedScience Ventures](https://shizune.co/investors/profile/medscience-ventures) - Total investments: 5 - Last investment: Jul 2026 - Lead investor: 20% - Last updated: Aug 2026 - LinkedIn: https://www.linkedin.com/in/patrick-aisher-292b439/ Patrick Aisher is a British-Austrian businessman who attended University in Montreal and London. He is Chairman of Kinled Holding Ltd in HK, which owns shares in a portfolio of more than 30 technology and medical companies. Mr. Aisher is a member of the Swiss Corporate Finance and Private Equity Association & the Swiss Finance and TechnologyAssociation. He directs Kinled Life Sciences Ventures Ltd, and is a Limited Partner in Concentric Team Technology I LP and MedScience Ventures LLC. He is also Director of a UK Charity that supports the under-privileged and unwell. ## Round sizes | Stage | Round size | | --- | --- | | Seed | $1.3M–$10M | ## Investment focus ### Industry | Industry | Investments | Share | | --- | --- | --- | | Health Care | 2 | 40% | | Medical Device | 2 | 40% | | SaaS | 1 | 20% | | Finance | 1 | 20% | | Leasing | 1 | 20% | 14 industries tracked in total. ### Stage | Stage | Investments | Share | | --- | --- | --- | | Seed | 2 | 40% | | Series B | 2 | 40% | | Pre-Seed | 1 | 20% | ### Country | Country | Investments | Share | | --- | --- | --- | | Switzerland | 2 | 40% | | Austria | 1 | 20% | | Finland | 1 | 20% | | United Kingdom | 1 | 20% | ## Investments | Company | Description | Amount | Stage | Date | Website | | --- | --- | --- | --- | --- | --- | | Cornea Sense | CorneaSense is a medtech startup developing a non-invasive, eye-based sensing device that measures ocular surface hydration to enable early detection and monitoring of conditions such as dry eye disease and systemic health disorders. The technology aims to provide real-time, objective eye biomarkers for improved clinical diagnosis and patient care. | $1.3M | Pre-Seed | Jul 13, 2026 | | | Linxfour - Transforming Equipment Finance | Linx4 is a one-stop equipment financing platform. | | Series B | Sep 19, 2023 | | | Unaric | Unaric buys, builds and grows Salesforce based SaaS companies and is backed by leading global investors. | $10M | Seed | Jun 28, 2023 | | | PreComb | PreComb develops technologies to optimally adapt the therapies to each patient for difficult to treat cancers to increase the success rates in cancer therapy. Only an efficient use of healthcare resources can lead to a maximum improvement in the quality of life of patients. | $1.3M | Seed | Oct 04, 2022 | | | KB Medical | KB Medical is a Swiss company focusing on design, development, and commercialization of the AQrate robotic system for assisting surgeons during the spinal surgery. Its AQrate robotic system’s technology and intellectual property empowers spinal surgeons with precise, cost-effective, robotic-assisted spinal fusion in a less hazardous workenvironment.KB Medical improves patients’ outcome and quality of life after a spinal fusion surgery as well as to reduce the received radiation by the OR team during the surgery. It is certified for the design and manufacture of assisted robotic system for spinal surgery accordingly to ISO 13485.KB Medical is based in Ecublens, Switzerland. | $2.9M | Series B | Oct 25, 2016 | | 5 of 5 investments shown. ## Co-investors - [Kinled Holding](https://shizune.co/investors/profile/kinled) — VC Fund, 2 deals together - [CCAP Investments & Advisory](https://shizune.co/investors/profile/ccap-investments-advisory) — VC Fund, 1 deal together - [Concentric](https://shizune.co/investors/profile/concentric) — VC Fund, 1 deal together - [Danube BioVentures](https://shizune.co/investors/profile/danube-bioventures) — VC Fund, 1 deal together - [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund, 1 deal together - [Innovestor](https://shizune.co/investors/profile/innovestor) — VC Fund, 1 deal together ## About MedScience Ventures VC Fund 1 contacts available at MedScience Ventures. | Name | Title | Profile | | --- | --- | --- | | Patrick Aisher | Limited Partner | https://shizune.co/investors/profile/patrick-aisher | ## Similar investors ### Similar industry - [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund - [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund - [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund ### Similar stage - [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund - [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund - [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund ### Similar country - [Business Finland](https://shizune.co/investors/profile/tekes) — VC Fund - [Lifeline Ventures](https://shizune.co/investors/profile/lifeline-ventures) — VC Fund - [Tesi](https://shizune.co/investors/profile/tesi) — VC Fund ## Featured in investor lists - [Medical Angel Investors in Finland](https://shizune.co/investors/medical-angel-investors-finland) ## FAQ ### What does Patrick Aisher invest in? Patrick Aisher invests primarily in Health Care, Medical Device and SaaS startups, most often at Seed and Series B stage. Most of the 5 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio. ### What is Patrick Aisher's check size? Patrick Aisher typically joins rounds of $1.3M–$10M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Patrick Aisher participates in. ### When did Patrick Aisher last invest? The most recent investment recorded for Patrick Aisher closed in Jul 2026. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly. ### Is Shizune's investor data accurate? Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page. # About Shizune Shizune.co is an investor database. Core features: - 48,091 startup investors (angels, VCs, accelerators, and others) - Email, phone, LinkedIn (for intros), socials, and other contact data - Updated daily from public funding news - CSV and Excel export The User can access the full database FOR FREE after signing up: shizune.co